Early research (Phase 1)Looking for participantsNCT04485013What this trial is testingTTX-080 HLA-G Antagonist in Subjects With Advanced CancersWho this might be right forCancer Tizona Therapeutics, Inc 240
Early research (Phase 1)Looking for participantsNCT07106827What this trial is testingGV20-0251 in Advanced or Refractory Solid TumorsWho this might be right forHCC - Hepatocellular CarcinomaCholangiocarcinomaMelanoma+5 more West China Hospital 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03008408What this trial is testingA Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial CarcinomaWho this might be right forRecurrent Endometrial CarcinomaRecurrent Endometrial Endometrioid AdenocarcinomaRefractory Endometrial Carcinoma+10 more M.D. Anderson Cancer Center 90
Early research (Phase 1)Looking for participantsNCT07227168What this trial is testingSTRO-004 in Adults With Refractory/Recurrent Metastatic CancerWho this might be right forHead and Neck Squamous Cell Carcinoma HNSCCNon-Small Cell Lung Cancer NSCLCEsophageal Cancer+6 more Sutro Biopharma, Inc. 200
Early research (Phase 1)Study completedNCT00003439What this trial is testingInterleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal CancerWho this might be right forCancer National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Ended earlyNCT05001282What this trial is testingEvaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)Who this might be right forOvarian CancerOvarian NeoplasmsOvarian Carcinoma+22 more Elucida Oncology 79
Early research (Phase 1)Ended earlyNCT03924245What this trial is testingOlaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube CancersWho this might be right forFallopian Tube CancerFallopian Tube CarcinosarcomaFallopian Tube Clear Cell Adenocarcinoma+10 more Vanderbilt-Ingram Cancer Center 3
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Early research (Phase 1)Ended earlyNCT05252416What this trial is testing(VELA) Study of BLU-222 in Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsHR+ Breast CancerCCNE1 Amplification+6 more Blueprint Medicines Corporation 50
Early research (Phase 1)Study completedNCT00082823What this trial is testingIntravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forCancer Regeneron Pharmaceuticals 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT03660826What this trial is testingTesting the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib AloneWho this might be right forEndometrial AdenocarcinomaEndometrial Mixed Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+3 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01631552What this trial is testingStudy of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial CancerWho this might be right forGastric AdenocarcinomaEsophageal CancerHepatocellular Carcinoma+13 more Gilead Sciences 515
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060What this trial is testingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more National Cancer Institute (NCI) 6,452
Not applicableEnded earlyNCT01271959What this trial is testingChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry StudyWho this might be right forSolid Organ Tumors Precision Therapeutics 167
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Looking for participantsNCT06999187What this trial is testingDR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory CarcinomasWho this might be right forTriple Negative Breast CancerHER2-negative Breast CancerNon Small Cell Lung Cancer+9 more Dren Bio 96
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Looking for participantsNCT05669430What this trial is testingGV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor MalignanciesWho this might be right forSolid Tumor, AdultRefractory CancerEndometrial Carcinoma (EC)+4 more GV20 Therapeutics 365
Testing effectiveness (Phase 2)Looking for participantsNCT04851119What this trial is testingTegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsWho this might be right forColorectal CarcinomaEndometrial CarcinomaMelanoma+19 more Children's Oncology Group 147
Testing effectiveness (Phase 2)Looking for participantsNCT05579366What this trial is testingRinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)Who this might be right forHigh Grade Epithelial Ovarian CancerHigh Grade Serous Ovarian CancerPrimary Peritoneal Carcinoma+12 more Genmab 764